Dermata Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Supports Ongoing Clinical Development Lucid Group LCID Q1 2026 Earnings Wider Loss Than Expected as Production Ramp Challenges Persist RILYP Q1 2024 Earnings Preferred Stock Reports Negative EPS Amid No Revenue Estimate Enpro Inc NPO Q1 2026 Earnings EPS Beats Estimates Amid Modest Stock Gain ABVX Q4 2025 Earnings Significant EPS Miss as DevelopmentStage Biotech Reports WiderThanExpected Loss Castle Biosciences Inc CSTL Q1 2026 Earnings NarrowerThanExpected Loss Drives Modest Optimism